Effects of alpha-lipoic acid on chemerin secretion in 3T3-L1 and human adipocytes.

[1]  M. Parmentier,et al.  Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. , 2011, Cytokine & growth factor reviews.

[2]  Á. Alonso-Castro,et al.  Isoorientin reverts TNF-α-induced insulin resistance in adipocytes activating the insulin signaling pathway. , 2012, Endocrinology.

[3]  M. Moreno-Aliaga,et al.  Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. , 2011, Molecular nutrition & food research.

[4]  B. Göke,et al.  Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet , 2010, Diabetes.

[5]  F. Accurso,et al.  Thioredoxin and dihydrolipoic acid inhibit elastase activity in cystic fibrosis sputum. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[6]  I. Padmalayam,et al.  Lipoic Acid Synthase (LASY) , 2009, Diabetes.

[7]  P. Arner,et al.  Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells , 2009, Diabetes.

[8]  T. Slaga,et al.  Up-regulation of Adiponectin by Resveratrol , 2010, The Journal of Biological Chemistry.

[9]  Gaochao Zhou,et al.  AMPK: an emerging drug target for diabetes and the metabolic syndrome. , 2009, Cell metabolism.

[10]  Sabrina Bauer,et al.  Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo , 2012, European journal of clinical investigation.

[11]  M. Moreno-Aliaga,et al.  Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats , 2013, European Journal of Nutrition.

[12]  M. Moreno-Aliaga,et al.  Effects of inhibiting transcription and protein synthesis on basal and insulin-stimulated leptin gene expression and leptin secretion in cultured rat adipocytes. , 2003, Biochemical and biophysical research communications.

[13]  M. Moreno-Aliaga,et al.  Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes , 2013, Journal of Physiology and Biochemistry.

[14]  Q. Wang,et al.  Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. , 2012, Chinese medical journal.

[15]  S. Parlee,et al.  Chemerin, a Novel Peroxisome Proliferator-activated Receptor γ (PPARγ) Target Gene That Promotes Mesenchymal Stem Cell Adipogenesis* , 2011, The Journal of Biological Chemistry.

[16]  M. Moreno-Aliaga,et al.  Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats , 2011, Journal of Physiology and Biochemistry.

[17]  M. Moreno-Aliaga,et al.  Effects of α‐lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss , 2015, Obesity.

[18]  B. Cheatham,et al.  Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes. , 1999, Diabetes.

[19]  L. Packer,et al.  R-α-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes , 2002 .

[20]  L. Packer,et al.  α-Lipoic Acid Inhibits Adipocyte Differentiation by Regulating Pro-adipogenic Transcription Factors via Mitogen-activated Protein Kinase Pathways* , 2003, Journal of Biological Chemistry.

[21]  M. Nishimura,et al.  Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. , 2006, Biochemical and biophysical research communications.

[22]  H. Lodish,et al.  Activation of AMP‐activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl‐CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  B. Shi,et al.  Association between Serum Chemerin Concentrations and Clinical Indices in Obesity or Metabolic Syndrome: A Meta-Analysis , 2014, PloS one.

[24]  M. Moreno-Aliaga,et al.  α‐lipoic acid reduces fatty acid esterification and lipogenesis in adipocytes from overweight/obese subjects , 2014, Obesity.

[25]  H. Randeva,et al.  Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin , 2009, Diabetes.

[26]  R. Moreau,et al.  Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. , 2009, Archives of biochemistry and biophysics.

[27]  R. Moreau,et al.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. , 2009, Biochimica et biophysica acta.

[28]  G. Cui,et al.  Identification of signaling pathways involved in aberrant production of adipokines in adipocytes undergoing oxidative stress. , 2009, Archives of medical research.

[29]  N. Iqbal,et al.  Role of multifunctional Chemerin in obesity and preclinical diabetes. , 2015, Obesity research & clinical practice.

[30]  J. Blangero,et al.  Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. , 2009, The Journal of clinical endocrinology and metabolism.

[31]  K. Goralski,et al.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. , 2010, Endocrinology.

[32]  S. Parlee,et al.  Elastase and Tryptase Govern TNFα-Mediated Production of Active Chemerin by Adipocytes , 2012, PloS one.

[33]  J. Lawrence,et al.  Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. , 2001, Diabetes.

[34]  D. Friebe,et al.  Chemerin as a mediator between obesity and vascular inflammation in children. , 2012, The Journal of clinical endocrinology and metabolism.

[35]  Wei-jian Zhang,et al.  α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway , 2007, Proceedings of the National Academy of Sciences.

[36]  M. Moreno-Aliaga,et al.  Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes[S] , 2012, Journal of Lipid Research.

[37]  S. Parlee,et al.  Chemerin: a potential endocrine link between obesity and type 2 diabetes , 2012, Endocrine.

[38]  Xianglin Shi,et al.  Lipoamide or lipoic acid stimulates mitochondrial biogenesis in 3T3‐L1 adipocytes via the endothelial NO synthase‐cGMP‐protein kinase G signalling pathway , 2011, British journal of pharmacology.

[39]  J. Stephens,et al.  Tumor Necrosis Factor-α-induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Substrate-1 and GLUT4 Expression without a Loss of Insulin Receptor-mediated Signal Transduction* , 1997, The Journal of Biological Chemistry.

[40]  I. Castan-Laurell,et al.  Apelin, a newly identified adipokine up-regulated by insulin and obesity. , 2005, Endocrinology.

[41]  T. Śledziński,et al.  Chemerin gene expression is regulated by food restriction and food restriction–refeeding in rat adipose tissue but not in liver , 2013, Regulatory Peptides.

[42]  D. Pipeleers,et al.  Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. , 2005, European journal of pharmacology.

[43]  L. Packer,et al.  The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. , 2007, Alternative medicine review : a journal of clinical therapeutic.

[44]  H. Motoshima,et al.  Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. , 2003, Diabetes.

[45]  M. Moreno-Aliaga,et al.  Lipoic acid prevents body weight gain induced by a high fat diet in rats: Effects on intestinal sugar transport , 2009, Journal of Physiology and Biochemistry.

[46]  C. Cobelli,et al.  alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. , 1999, Diabetes care.

[47]  P. Zimmet,et al.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome. , 2007, Endocrinology.

[48]  M. Reiser,et al.  Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. , 2009, European journal of endocrinology.

[49]  S. Ryu,et al.  Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress. , 2010, Analytical biochemistry.

[50]  S. Parlee,et al.  Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. , 2010, Endocrinology.

[51]  K. Clément,et al.  Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. , 2010, The Journal of clinical endocrinology and metabolism.

[52]  G. Chrousos,et al.  Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: Adipose depot specificity and gender dimorphism , 2012, Molecules and cells.

[53]  T. Abe,et al.  Chemerin regulates β-cell function in mice , 2011, Scientific reports.

[54]  E. Butcher,et al.  Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. , 2012, Endocrinology.

[55]  M. Moreno-Aliaga,et al.  α-Lipoic acid treatment increases mitochondrial biogenesis and promotes beige adipose features in subcutaneous adipocytes from overweight/obese subjects. , 2015, Biochimica et biophysica acta.

[56]  M. Moreno-Aliaga,et al.  Antiobesity effects of a–lipoic acid supplementation , 2013 .

[57]  Shantao Liu,et al.  Alpha‐lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway , 2008, FEBS letters.

[58]  M. Moreno-Aliaga,et al.  Sp1-mediated transcription is involved in the induction of leptin by insulin-stimulated glucose metabolism. , 2007, Journal of molecular endocrinology.

[59]  L. Recht,et al.  Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma* , 2011, The Journal of Biological Chemistry.

[60]  R. Somwar,et al.  Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes , 2000, Diabetologia.